SEC Tracker › Insiders › Jens Holstein
Holdings now As reported after the latest Form 3, 4 or 5 at each company.
How these figures work Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.
Company Security Held Shares or units As of Veracyte VCYT Common Stock Directly 27,471 Oct 27, 2026 · Filing · EDGAR Veracyte VCYT Stock Option (right to buy)exercise $35.30, expires Aug 1, 2030, into Common Stock
Directly 20,000 Oct 27, 2026 · Filing · EDGAR
Sold and noticed by quarter Jens Holstein: dollars sold on Form 4 and noticed on Form 144 per quarter, Q2 2021 to Q4 2026 $557K $0 Q2 2021: $0 noticed on Form 144 Q2 2021: $0 sold on Form 4 Q2 2021: $70K bought Q3 2021: $0 noticed on Form 144 Q3 2021: $0 sold on Form 4 Q4 2021: $0 noticed on Form 144 Q4 2021: $0 sold on Form 4 Q1 2022: $0 noticed on Form 144 Q1 2022: $0 sold on Form 4 Q2 2022: notice not machine-readable Q2 2022: $142K sold on Form 4 Q3 2022: $0 noticed on Form 144 Q3 2022: $0 sold on Form 4 Q4 2022: $0 noticed on Form 144 Q4 2022: $0 sold on Form 4 Q1 2023: $0 noticed on Form 144 Q1 2023: $0 sold on Form 4 Q2 2023: $0 noticed on Form 144 Q2 2023: $0 sold on Form 4 Q3 2023: $0 noticed on Form 144 Q3 2023: $0 sold on Form 4 Q4 2023: $0 noticed on Form 144 Q4 2023: $0 sold on Form 4 Q1 2024: $0 noticed on Form 144 Q1 2024: $0 sold on Form 4 Q2 2024: $0 noticed on Form 144 Q2 2024: $0 sold on Form 4 Q3 2024: $0 noticed on Form 144 Q3 2024: $268K sold on Form 4 Q4 2024: $0 noticed on Form 144 Q4 2024: $0 sold on Form 4 Q1 2025: $0 noticed on Form 144 Q1 2025: $0 sold on Form 4 Q2 2025: $0 noticed on Form 144 Q2 2025: $0 sold on Form 4 Q3 2025: $0 noticed on Form 144 Q3 2025: $0 sold on Form 4 Q4 2025: $424K noticed on Form 144 Q4 2025: $424K sold on Form 4 Q1 2026: $0 noticed on Form 144 Q1 2026: $0 sold on Form 4 Q2 2026: $0 noticed on Form 144 Q2 2026: $0 sold on Form 4 Q3 2026: $557K noticed on Form 144 Q3 2026: $557K sold on Form 4 Q4 2026: $375K noticed on Form 144 Q4 2026: $375K sold on Form 4 Q2 2021 Q3 2022 Q4 2023 Q1 2025 Q2 2026 Sold (Form 4) Noticed (Form 144) Bought (Form 4)
Quarterly totals as a table Quarter Sold (Form 4) Noticed (Form 144) Bought (Form 4) Q4 2026 $375K $375K — Q3 2026 $557K $557K — Q4 2025 $424K $424K — Q3 2024 $268K — — Q2 2022 $142K Not machine-readable — Q2 2021 — — $70K
Form 144 notices went onto EDGAR as structured data on April 13, 2023. Earlier notices were filed on paper and cannot be read here, so those quarters show no noticed amount.
Planned sales (Form 144) and the sales that followed Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.
How we match A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.
Notice date Noticed Planned sale Outcome Links Veracyte VCYT · Morgan Stanley Smith Barney · 10b5-1 plan adopted Jun 12, 2026 · 3 noticesOct 27, 2026 7,500 · ~$375K Oct 27, 2026 Sold as noticed Sold 7,500 at $50.00 on Oct 27 · $375K Form 4 Filing · EDGAR Sep 24, 2026 7,500 · ~$353K Sep 24, 2026 Sold as noticed Sold 7,500 at $47.00 on Sep 24 · $353K Form 4 Filing · EDGAR Sep 14, 2026 5,000 · ~$205K Sep 14, 2026 Sold as noticed Sold 5,000 at $40.95 on Sep 14 · $205K Form 4 Filing · EDGAR Veracyte VCYT · Morgan Stanley Smith Barney · 10b5-1 plan adopted Aug 21, 2025 · 1 noticeNov 20, 2025 10,000 · ~$424K Nov 20, 2025 Sold as noticed Sold 10,000 in 3 sales, Nov 20 to Nov 20 · $424K Form 4 Filing · EDGAR Sales without a matching Form 144 · 5 salesNo matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
— — — Sold without notice Veracyte (VCYT): Sold 2,500 at $30.00 on Aug 7, 2024 · $75K (10b5-1 plan) Filing · EDGAR — — — Sold without notice Veracyte (VCYT): Sold 2,500 at $28.00 on Aug 7, 2024 · $70K (10b5-1 plan) Filing · EDGAR — — — Sold without notice Veracyte (VCYT): Sold 2,500 at $25.00 on Jul 16, 2024 · $63K (10b5-1 plan) Filing · EDGAR — — — Sold without notice Veracyte (VCYT): Sold 2,500 at $24.00 on Jul 16, 2024 · $60K (10b5-1 plan) Filing · EDGAR — — — Notice not machine-readable Veracyte (VCYT): Sold 8,720 at $16.27 on Jun 14, 2022 · $142K Filing · EDGAR
Every transaction, by company Each Form 3, 4 and 5 transaction in plain words, newest first.
How these figures work Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.
Veracyte VCYT Director · filings 2020 to 2026 · sold $1.8M · bought $70K · $1.4M noticed on Form 144 Date Transaction Shares Price Value Held after Source Oct 27, 2026 Option or RSU exercised or converted +7,500 $35.30 $265K 34,971 direct Filing · EDGAR Oct 27, 2026 Sale under a 10b5-1 plan −7,500 $50.00 $375K 27,471 direct Filing · EDGAR Oct 27, 2026 Option or RSU exercised or converted Stock Option (right to buy)
−7,500 20,000 direct Filing · EDGAR Sep 24, 2026 Option or RSU exercised or converted +7,500 $35.30 $265K 34,971 direct Filing · EDGAR Sep 24, 2026 Sale under a 10b5-1 plan −7,500 $47.00 $353K 27,471 direct Filing · EDGAR Sep 24, 2026 Option or RSU exercised or converted Stock Option (right to buy)
−7,500 27,500 direct Filing · EDGAR Sep 14, 2026 Sale under a 10b5-1 plan −5,000 $40.95 $205K 27,471 direct Filing · EDGAR Jun 11, 2026 Grant or award from the company +5,272 32,471 direct Filing · EDGAR Nov 20, 2025 Sale under a 10b5-1 plan −1,491 $40.95 $61K 35,708 direct Filing · EDGAR Nov 20, 2025 Sale under a 10b5-1 plan −7,049 $42.48 $299K 28,659 direct Filing · EDGAR Nov 20, 2025 Sale under a 10b5-1 plan −1,460 $43.21 $63K 27,199 direct Filing · EDGAR Jun 18, 2025 Grant or award from the company +9,321 37,199 direct Filing · EDGAR Aug 7, 2024 Sale under a 10b5-1 plan −2,500 $28.00 $70K 30,378 direct Filing · EDGAR Aug 7, 2024 Sale under a 10b5-1 plan −2,500 $30.00 $75K 27,878 direct Filing · EDGAR Jul 16, 2024 Sale under a 10b5-1 plan −2,500 $24.00 $60K 35,378 direct Filing · EDGAR Jul 16, 2024 Sale under a 10b5-1 plan −2,500 $25.00 $63K 32,878 direct Filing · EDGAR Jun 13, 2024 Grant or award from the company +11,473 37,878 direct Filing · EDGAR Jun 9, 2023 Grant or award from the company +9,674 26,405 direct Filing · EDGAR Jun 16, 2022 Grant or award from the company +14,731 16,731 direct Filing · EDGAR Jun 14, 2022 Open-market or private sale −8,720 $16.27 $142K 2,000 direct Filing · EDGAR Jun 8, 2021 Grant or award from the company +8,720 10,720 direct Filing · EDGAR Jun 3, 2021 Open-market or private purchase +2,000 $35.19 $70K 2,000 direct Filing · EDGAR Aug 1, 2020 Grant or award from the company 35000
+35,000 35,000 direct Filing · EDGAR
All 18 Forms 3, 4, 5 and 144 Filed Form Company Links Oct 28, 2026 Form 4 Veracyte VCYT Filing · EDGAR Oct 27, 2026 Form 144 Veracyte VCYT Filing · EDGAR Sep 24, 2026 Form 144 Veracyte VCYT Filing · EDGAR Sep 16, 2026 Form 4 Veracyte VCYT Filing · EDGAR Sep 14, 2026 Form 144 Veracyte VCYT Filing · EDGAR Jun 15, 2026 Form 4 Veracyte VCYT Filing · EDGAR Nov 21, 2025 Form 4 Veracyte VCYT Filing · EDGAR Nov 20, 2025 Form 144 Veracyte VCYT Filing · EDGAR Jun 23, 2025 Form 4 Veracyte VCYT Filing · EDGAR Aug 9, 2024 Form 4 Veracyte VCYT Filing · EDGAR Jul 18, 2024 Form 4 Veracyte VCYT Filing · EDGAR Jun 17, 2024 Form 4 Veracyte VCYT Filing · EDGAR Jun 13, 2023 Form 4 Veracyte VCYT Filing · EDGAR Jun 16, 2022 Form 4 Veracyte VCYT Filing · EDGAR Jun 10, 2021 Form 4 Veracyte VCYT Filing · EDGAR Jun 4, 2021 Form 4 Veracyte VCYT Filing · EDGAR Aug 6, 2020 Form 3 Veracyte VCYT Filing · EDGAR Aug 4, 2020 Form 4 Veracyte VCYT Filing · EDGAR
Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.
Data on this page was fetched Nov 8, 2026, 7:17 AM ET . The filing on SEC.gov is the record.